Exact Mass: 451.2444094
Exact Mass Matches: 451.2444094
Found 500 metabolites which its exact mass value is equals to given mass value 451.2444094
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Piscerythramine
C26H29NO6 (451.19947740000003)
A hydroxyisoflavone that is isoflavone substituted by hydroxy groups at positions 5, 7 and 3, prenyl groups at positions 2 and 6, a methoxy group at position 5 and an amino group at position 4.
Cytochalasin Opho
C28H37NO4 (451.27224420000005)
Cytochalasin Opho is a mycotoxin produced by Phomopsis sp Mycotoxin production by Phomopsis species
14alpha-Hydroxypaxilline
C27H33NO5 (451.23586080000007)
14alpha-Hydroxypaxilline is a metabolite from Penicillium paxilli. Also identified chromatographically in Acremonium lolii. Metabolite from Penicillium paxilliand is) also identified chromatographically in Acremonium lolii
LysoPE(16:1(9Z)/0:0)
C21H42NO7P (451.26987520000006)
LysoPE(16:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(16:1(9Z)/0:0) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
LysoPE(0:0/16:1(9Z))
C21H42NO7P (451.26987520000006)
LysoPE(0:0/16:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms. [HMDB] LysoPE(0:0/16:1(9Z)) is a lysophosphatidylethanolamine or a lysophospholipid. The term lysophospholipid (LPL) refers to any phospholipid that is missing one of its two O-acyl chains. Thus, LPLs have a free alcohol in either the sn-1 or sn-2 position. The prefix lyso- comes from the fact that lysophospholipids were originally found to be hemolytic however it is now used to refer generally to phospholipids missing an acyl chain. LPLs are usually the result of phospholipase A-type enzymatic activity on regular phospholipids such as phosphatidylcholine or phosphatidic acid, although they can also be generated by the acylation of glycerophospholipids or the phosphorylation of monoacylglycerols. Some LPLs serve important signaling functions such as lysophosphatidic acid. Lysophosphatidylethanolamines (LPEs) can function as plant growth regulators with several diverse uses. (LPEs) are approved for outdoor agricultural use to accelerate ripening and improve the quality of fresh produce. They are also approved for indoor use to preserve stored crops and commercial cut flowers. As a breakdown product of phosphatidylethanolamine (PE), LPE is present in cells of all organisms.
4-Hydroxyvalsartan
C24H29N5O4 (451.22194340000004)
4-Hydroxyvalsartan is only found in individuals that have used or taken Valsartan. 4-Hydroxyvalsartan is a metabolite of Valsartan. 4-hydroxyvalsartan belongs to the family of Biphenyltetrazoles and Derivatives. These are organic compounds containing a biphenyl attached to a tetrazole. A carbon atom of the biphenyl moiety is boned to a carbon or the nitrogen atom of the tetrazole moiety.
Enterocin 900
C31H33NO2 (451.25111580000004)
Enterocin 900 is found in fruits. Enterocin 900 is produced by Enterococcus faecium BFE900 from black olives.
(10E,12E,14E)-9-Hydroxy-16-oxooctadeca-10,12,14-trienoylcarnitine
C25H41NO6 (451.29337260000005)
(10E,12E,14E)-9-hydroxy-16-oxooctadeca-10,12,14-trienoylcarnitine is an acylcarnitine. More specifically, it is an (10E,12E,14E)-9-hydroxy-16-oxooctadeca-10,12,14-trienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (10E,12E,14E)-9-hydroxy-16-oxooctadeca-10,12,14-trienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (10E,12E,14E)-9-hydroxy-16-oxooctadeca-10,12,14-trienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
(10E,12E,14E)-16-Hydroxy-9-oxooctadeca-10,12,14-trienoylcarnitine
C25H41NO6 (451.29337260000005)
(10E,12E,14E)-16-hydroxy-9-oxooctadeca-10,12,14-trienoylcarnitine is an acylcarnitine. More specifically, it is an (10E,12E,14E)-16-hydroxy-9-oxooctadeca-10,12,14-trienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (10E,12E,14E)-16-hydroxy-9-oxooctadeca-10,12,14-trienoylcarnitine is therefore classified as a long chain AC. As a long-chain acylcarnitine (10E,12E,14E)-16-hydroxy-9-oxooctadeca-10,12,14-trienoylcarnitine is generally formed through esterification with long-chain fatty acids obtained from the diet. The main function of most long-chain acylcarnitines is to ensure long chain fatty acid transport into the mitochondria (PMID: 22804748). Altered levels of long-chain acylcarnitines can serve as useful markers for inherited disorders of long-chain fatty acid metabolism. Carnitine palmitoyltransferase I (CPT I, EC:2.3.1.21) is involved in the synthesis of long-chain acylcarnitines (more than C12) on the mitochondrial outer membrane. Elevated serum/plasma levels of long-chain acylcarnitines are not only markers for incomplete FA oxidation but also are indicators of altered carbohydrate and lipid metabolism. High serum concentrations of long-chain acylcarnitines in the postprandial or fed state are markers of insulin resistance and arise from insulins inability to inhibit CPT-1-dependent fatty acid metabolism in muscles and the heart (PMID: 19073774). Increased intracellular content of long-chain acylcarnitines is thought to serve as a feedback inhibition mechanism of insulin action (PMID: 23258903). In healthy subjects, increased concentrations of insulin effectively inhibits long-chain acylcarnitine production. Several studies have also found increased levels of circulating long-chain acylcarnitines in chronic heart failure patients (PMID: 26796394). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
1-Hydroxytrimazosin
Cenisertib
Dibekacin
Dihydroxylysinonorleucine
tetrahydrogeranylgeranyl-PP
Tetrahydrogeranylgeranyl-pp is practically insoluble (in water) and a moderately acidic compound (based on its pKa). Tetrahydrogeranylgeranyl-pp can be found in a number of food items such as muskmelon, wax gourd, deerberry, and pineapple, which makes tetrahydrogeranylgeranyl-pp a potential biomarker for the consumption of these food products.
Chasmanin
C25H41NO6 (451.29337260000005)
Chasmanine is a natural product found in Aconitum japonicum, Aconitum triphyllum, and other organisms with data available.
Chasmanine
C25H41NO6 (451.29337260000005)
A diterpene alkaloid with formula C25H41NO6 that is isolated from several Aconitum species.
Isopiscerythramine
C26H29NO6 (451.19947740000003)
dysidine
C23H33NO6S (451.2028478000001)
A sesquiterpenoid isolated from the sponge Dysidea sp. that is 5-amino-2-hydroxy-3-methyl-1,4-benzoquinone in which one of the hydrogens of the methyl group is replaced by a 1,2,4a,5-tetramethyl-1,2,3,4,4a,7,8,8a-octahydronaphthalen-2-yl group and one of the hydrogens attached to the nitrogen is replaced by a 2-sulfoethyl group. Dysidine selectively inhibits human synovial phospholipase A2 (EC 3.1.1.4) with an IC50 = 2.0 muM.
20-ethyl-1,14-dimethoxy-4-methyl-7,8-methylenedioxy-1alpha,5R,6beta,9S,14alpha,16beta-aconitane-6,10,16-triol|deacetylelasine
N-Methyl-L-isoleucyl-L-amiclenomycyl-L-glutamine
C22H37N5O5 (451.27945520000003)
(E)-3-(methylsulfonyl)-propenoic acid (2E,6E)-4-(8-hydroxy-3,7-dimethyl-2,6-octadienyloxy)-3-methoxyphenethyl amide|O-methylsakerinol A
C23H33NO6S (451.2028478000001)
methyl beta-fucopyranosyl(1->4)-beta-saccharosaminopyranosyl(1->4)-beta-digitoxopyranoside
(2S,4aR,4bR,6aS,12bS,12cS,14aS)-4a-demethylpaspaline-4a-carboxylic acid
C28H37NO4 (451.27224420000005)
(2R,4bS,6aS,12bS,12cR,14aS)-2-hydroxypaxilline
C27H33NO5 (451.23586080000007)
9beta,2-dihydroxy-4,5-dimethoxy-lythran-12-one|9beta-hydroxyvertine
C26H29NO6 (451.19947740000003)
(15aR)-17c-hydroxy-(15ar,19acC13)-16,7,8,9,55,6-hexahydro-15aH-10-aza-1(2,9a)-dibenzofurana-5(1,3)-pyrimidina-cyclotridecaphane-2t,12t-diene-4,11-dione|3alpha-hydroxy-21,25-methanediyl-3-deoxo-lunarine|Alkaloid LBZ|alkaloid LBZ (Lunaria)|N21,N25-methanediyl-lunarinol-II
C26H33N3O4 (451.2470938000001)
Ala Ala Lys Tyr
C21H33N5O6 (451.24307180000005)
Ala Ala Gln Tyr
Ala Ala Tyr Lys
C21H33N5O6 (451.24307180000005)
Ala Ala Tyr Gln
Ala Phe Lys Ser
C21H33N5O6 (451.24307180000005)
Ala Phe Asn Thr
Ala Phe Gln Ser
Ala Phe Ser Lys
C21H33N5O6 (451.24307180000005)
Ala Phe Ser Gln
Ala Phe Thr Asn
Ala His Lys Pro
C20H33N7O5 (451.25430480000006)
Ala His Pro Lys
C20H33N7O5 (451.25430480000006)
Ala His Pro Gln
Ala His Gln Pro
Ala Lys Ala Tyr
C21H33N5O6 (451.24307180000005)
Ala Lys Phe Ser
C21H33N5O6 (451.24307180000005)
Ala Lys His Pro
C20H33N7O5 (451.25430480000006)
Ala Lys Pro His
C20H33N7O5 (451.25430480000006)
Ala Lys Ser Phe
C21H33N5O6 (451.24307180000005)
Ala Lys Tyr Ala
C21H33N5O6 (451.24307180000005)
Ala Asn Phe Thr
Ala Asn Thr Phe
Ala Pro His Lys
C20H33N7O5 (451.25430480000006)
Ala Pro His Gln
Ala Pro Lys His
C20H33N7O5 (451.25430480000006)
Ala Pro Gln His
Ala Gln Ala Tyr
Ala Gln Phe Ser
Ala Gln His Pro
Ala Gln Pro His
Ala Gln Ser Phe
Ala Gln Tyr Ala
Ala Ser Phe Lys
C21H33N5O6 (451.24307180000005)
Ala Ser Phe Gln
Ala Ser Lys Phe
C21H33N5O6 (451.24307180000005)
Ala Ser Gln Phe
Ala Thr Phe Asn
Ala Thr Asn Phe
Ala Tyr Ala Lys
C21H33N5O6 (451.24307180000005)
Ala Tyr Ala Gln
Ala Tyr Lys Ala
C21H33N5O6 (451.24307180000005)
Ala Tyr Gln Ala
Cys Lys Thr Thr
Cys Thr Lys Thr
Cys Thr Thr Lys
Phe Ala Lys Ser
C21H33N5O6 (451.24307180000005)
Phe Ala Asn Thr
Phe Ala Gln Ser
Phe Ala Ser Lys
C21H33N5O6 (451.24307180000005)
Phe Ala Ser Gln
Phe Ala Thr Asn
Phe Gly Lys Thr
C21H33N5O6 (451.24307180000005)
Phe Gly Gln Thr
Phe Gly Thr Lys
C21H33N5O6 (451.24307180000005)
Phe Gly Thr Gln
Phe Lys Ala Ser
C21H33N5O6 (451.24307180000005)
Phe Lys Gly Thr
C21H33N5O6 (451.24307180000005)
Phe Lys Ser Ala
C21H33N5O6 (451.24307180000005)
Phe Lys Thr Gly
C21H33N5O6 (451.24307180000005)
Phe Asn Ala Thr
Phe Asn Thr Ala
Phe Gln Ala Ser
Phe Gln Gly Thr
Phe Gln Ser Ala
Phe Gln Thr Gly
Phe Ser Ala Lys
C21H33N5O6 (451.24307180000005)
Phe Ser Ala Gln
Phe Ser Lys Ala
C21H33N5O6 (451.24307180000005)
Phe Ser Gln Ala
Phe Thr Ala Asn
Phe Thr Gly Lys
C21H33N5O6 (451.24307180000005)
Phe Thr Gly Gln
Phe Thr Lys Gly
C21H33N5O6 (451.24307180000005)
Phe Thr Asn Ala
Phe Thr Gln Gly
Gly Phe Lys Thr
C21H33N5O6 (451.24307180000005)
Gly Phe Gln Thr
Gly Phe Thr Lys
C21H33N5O6 (451.24307180000005)
Gly Phe Thr Gln
Gly Gly Arg Tyr
Gly Gly Tyr Arg
Gly Lys Phe Thr
C21H33N5O6 (451.24307180000005)
Gly Lys Thr Phe
C21H33N5O6 (451.24307180000005)
Gly Asn Val Tyr
Gly Asn Tyr Val
Gly Gln Phe Thr
Gly Gln Thr Phe
Gly Arg Gly Tyr
Gly Arg Tyr Gly
Gly Thr Phe Lys
C21H33N5O6 (451.24307180000005)
Gly Thr Phe Gln
Gly Thr Lys Phe
C21H33N5O6 (451.24307180000005)
Gly Thr Gln Phe
Gly Val Asn Tyr
Gly Val Tyr Asn
Gly Tyr Gly Arg
Gly Tyr Asn Val
Gly Tyr Arg Gly
Gly Tyr Val Asn
His Ala Lys Pro
C20H33N7O5 (451.25430480000006)
His Ala Pro Lys
C20H33N7O5 (451.25430480000006)
His Ala Pro Gln
His Ala Gln Pro
His Lys Ala Pro
C20H33N7O5 (451.25430480000006)
His Lys Pro Ala
C20H33N7O5 (451.25430480000006)
His Pro Ala Lys
C20H33N7O5 (451.25430480000006)
His Pro Ala Gln
His Pro Lys Ala
C20H33N7O5 (451.25430480000006)
His Pro Gln Ala
His Gln Ala Pro
His Gln Pro Ala
Lys Ala Ala Tyr
C21H33N5O6 (451.24307180000005)
Lys Ala Phe Ser
C21H33N5O6 (451.24307180000005)
Lys Ala His Pro
C20H33N7O5 (451.25430480000006)
Lys Ala Pro His
C20H33N7O5 (451.25430480000006)
Lys Ala Ser Phe
C21H33N5O6 (451.24307180000005)
Lys Ala Tyr Ala
C21H33N5O6 (451.24307180000005)
Lys Cys Thr Thr
Lys Phe Ala Ser
C21H33N5O6 (451.24307180000005)
Lys Phe Gly Thr
C21H33N5O6 (451.24307180000005)
Lys Phe Ser Ala
C21H33N5O6 (451.24307180000005)
Lys Phe Thr Gly
C21H33N5O6 (451.24307180000005)
Lys Gly Phe Thr
C21H33N5O6 (451.24307180000005)
Lys Gly Thr Phe
C21H33N5O6 (451.24307180000005)
Lys His Ala Pro
C20H33N7O5 (451.25430480000006)
Lys His Pro Ala
C20H33N7O5 (451.25430480000006)
Lys Met Ser Ser
Lys Pro Ala His
C20H33N7O5 (451.25430480000006)
Lys Pro His Ala
C20H33N7O5 (451.25430480000006)
Lys Ser Ala Phe
C21H33N5O6 (451.24307180000005)
Lys Ser Phe Ala
C21H33N5O6 (451.24307180000005)
Lys Ser Met Ser
Lys Ser Ser Met
Lys Thr Cys Thr
Lys Thr Phe Gly
C21H33N5O6 (451.24307180000005)
Lys Thr Gly Phe
C21H33N5O6 (451.24307180000005)
Lys Thr Thr Cys
Lys Tyr Ala Ala
C21H33N5O6 (451.24307180000005)
Met Lys Ser Ser
Met Ser Lys Ser
Met Ser Ser Lys
Asn Ala Phe Thr
Asn Ala Thr Phe
Asn Phe Ala Thr
Asn Phe Thr Ala
Asn Gly Val Tyr
Asn Gly Tyr Val
Asn Thr Ala Phe
Asn Thr Phe Ala
Asn Val Gly Tyr
Asn Val Tyr Gly
Asn Tyr Gly Val
Asn Tyr Val Gly
Pro Ala His Lys
C20H33N7O5 (451.25430480000006)
Pro Ala His Gln
Pro Ala Lys His
C20H33N7O5 (451.25430480000006)
Pro Ala Gln His
Pro His Ala Lys
C20H33N7O5 (451.25430480000006)
Pro His Ala Gln
Pro His Lys Ala
C20H33N7O5 (451.25430480000006)
Pro His Gln Ala
Pro Lys Ala His
C20H33N7O5 (451.25430480000006)
Pro Lys His Ala
C20H33N7O5 (451.25430480000006)
Pro Gln Ala His
Pro Gln His Ala
Gln Ala Ala Tyr
Gln Ala Phe Ser
Gln Ala His Pro
Gln Ala Pro His
Gln Ala Ser Phe
Gln Ala Tyr Ala
Gln Phe Ala Ser
Gln Phe Gly Thr
Gln Phe Ser Ala
Gln Phe Thr Gly
Gln Gly Phe Thr
Gln Gly Thr Phe
Gln His Ala Pro
Gln His Pro Ala
Gln Pro Ala His
Gln Pro His Ala
Gln Ser Ala Phe
Gln Ser Phe Ala
Gln Thr Phe Gly
Gln Thr Gly Phe
Gln Tyr Ala Ala
Arg Gly Gly Tyr
Arg Gly Tyr Gly
Arg Tyr Gly Gly
Ser Ala Phe Lys
C21H33N5O6 (451.24307180000005)
Ser Ala Phe Gln
Ser Ala Lys Phe
C21H33N5O6 (451.24307180000005)
Ser Ala Gln Phe
Ser Phe Ala Lys
C21H33N5O6 (451.24307180000005)
Ser Phe Ala Gln
Ser Phe Lys Ala
C21H33N5O6 (451.24307180000005)
Ser Phe Gln Ala
Ser Lys Ala Phe
C21H33N5O6 (451.24307180000005)
Ser Lys Phe Ala
C21H33N5O6 (451.24307180000005)
Ser Lys Met Ser
Ser Lys Ser Met
Ser Met Lys Ser
Ser Met Ser Lys
Ser Gln Ala Phe
Ser Gln Phe Ala
Ser Ser Lys Met
Ser Ser Met Lys
Thr Ala Phe Asn
Thr Ala Asn Phe
Thr Cys Lys Thr
Thr Cys Thr Lys
Thr Phe Ala Asn
Thr Phe Gly Lys
C21H33N5O6 (451.24307180000005)
Thr Phe Gly Gln
Thr Phe Lys Gly
C21H33N5O6 (451.24307180000005)
Thr Phe Asn Ala
Thr Phe Gln Gly
Thr Gly Phe Lys
C21H33N5O6 (451.24307180000005)
Thr Gly Phe Gln
Thr Gly Lys Phe
C21H33N5O6 (451.24307180000005)
Thr Gly Gln Phe
Thr Lys Cys Thr
Thr Lys Phe Gly
C21H33N5O6 (451.24307180000005)
Thr Lys Gly Phe
C21H33N5O6 (451.24307180000005)
Thr Lys Thr Cys
Thr Asn Ala Phe
Thr Asn Phe Ala
Thr Gln Phe Gly
Thr Gln Gly Phe
Thr Thr Cys Lys
Thr Thr Lys Cys
Val Gly Asn Tyr
Val Gly Tyr Asn
Val Asn Gly Tyr
Val Asn Tyr Gly
Val Tyr Gly Asn
Val Tyr Asn Gly
Tyr Ala Ala Lys
C21H33N5O6 (451.24307180000005)
Tyr Ala Ala Gln
Tyr Ala Lys Ala
C21H33N5O6 (451.24307180000005)
Tyr Ala Gln Ala
Tyr Gly Gly Arg
Tyr Gly Asn Val
Tyr Gly Arg Gly
Tyr Gly Val Asn
Tyr Lys Ala Ala
C21H33N5O6 (451.24307180000005)
Tyr Asn Gly Val
Tyr Asn Val Gly
Tyr Gln Ala Ala
Tyr Arg Gly Gly
Tyr Val Gly Asn
Tyr Val Asn Gly
Platelet-activating factor
C21H42NO7P (451.26987520000006)
dibekacin
J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01G - Aminoglycoside antibacterials A kanamycin that is kanamycin B lacking the 3- and 4-hydroxy groups on the 2,6-diaminosugar ring. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics C784 - Protein Synthesis Inhibitor > C2363 - Aminoglycoside Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
4-Hydroxyvalsartan
C24H29N5O4 (451.22194340000004)
Cytochalasin Opho
C28H37NO4 (451.27224420000005)
Enterocin 900
C31H33NO2 (451.25111580000004)
7-Hydroxypaxilline
C27H33NO5 (451.23586080000007)
4-Cyano-4-biphenylyl 4-(trans-4-pentylcyclohexyl)benzoate
C31H33NO2 (451.25111580000004)
3-(2H-Benzotriazolyl)-5-(1,1-di-methylethyl)-4-hydroxy-benzenepropanoic acid octyl esters
n-2-nitrophenylsulfenyl-l-valine dicyclohexylammonium salt
C23H37N3O4S (451.25046420000007)
AZ 628
AZ 628 is a pan-Raf kinase inhibitor with IC50s of 105, 34 and 29 nM for B-Raf, B-RafV600E, and c-Raf-1, respectively.
Cenisertib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor Cenisertib (AS-703569) is an ATP-competitive multi-kinase inhibitor that blocks the activity of Aurora-kinase-A/B, ABL1, AKT, STAT5 and FLT3. Cenisertib induces major growth-inhibitory effects by blocking the activity of several different molecular targets in neoplastic mast cells (MC). Cenisertib inhibits tumor growth in xenograft models of pancreatic, breast, colon, ovarian, and lung tumors and leukemia[1][2][3].
(1r)-1-[(4-{[(6,7-Dihydro[1,4]dioxino[2,3-C]pyridazin-3-Yl)methyl]amino}piperidin-1-Yl)methyl]-9-Fluoro-1,2-Dihydro-4h-Pyrrolo[3,2,1-Ij]quinolin-4-One
C24H26FN5O3 (451.20195780000006)
2-(4-Dimethylaminophenyl)-5-(4-methyl-1-piperazinyl)-2,5-BI-benzimidazole
Sanfetrinem cilexetil
C23H33NO8 (451.22060580000004)
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
2-(butan-2-ylamino)-N-[4-[5-[[2-(butan-2-ylamino)acetyl]amino]-1,3-benzoxazol-2-yl]phenyl]acetamide
C25H33N5O3 (451.2583268000001)
4-[4-(1-Amino-1-methylethyl)phenyl]-5-chloro-N-[4-(2-morpholin-4-ylethyl)phenyl]pyrimidin-2-amine
N-(4-{[(3s)-3-(Dimethylamino)pyrrolidin-1-Yl]carbonyl}phenyl)-5-Fluoro-4-[2-Methyl-1-(1-Methylethyl)-1h-Imidazol-5-Yl]pyrimidin-2-Amine
[(3S)-3,4-di(hexanoyloxy)butyl]-[2-(trimethylazaniumyl)ethoxy]phosphinate
C21H42NO7P (451.26987520000006)
2-[[5-[(1,2,4a,5-Tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-6-hydroxy-3,4-dioxocyclohexa-1,5-dien-1-yl]amino]ethanesulfonic acid
C23H33NO6S (451.2028478000001)
1-(9Z-hexadecenoyl)-sn-glycero-3-phosphoethanolamine
C21H42NO7P (451.26987520000006)
(2S)-3-(4-hydroxyphenyl)-2-[(4E,6E,8E,10E,12E)-2,6,10,12-tetramethyl-3-oxotetradeca-4,6,8,10,12-pentaenamido]propanoate
C27H33NO5 (451.23586080000007)
a 1-acyl-sn-glycero-3-phosphoethanolamine (n-C16:1)
C21H42NO7P (451.26987520000006)
a 2-acyl-sn-glycero-3-phosphoethanolamine (n-C16:1)
C21H42NO7P (451.26987520000006)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] hexadec-7-enoate
C21H42NO7P (451.26987520000006)
[(2R)-1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-hydroxypropan-2-yl] (E)-hexadec-11-enoate
C21H42NO7P (451.26987520000006)
[oxido-[(2E)-3,7,11,15-tetramethylhexadeca-2,14-dienoxy]phosphoryl] phosphate
6-Amino-2-[2-[(5-amino-1-carboxy-4-hydroxypentyl)amino]-2-(1-carboxypentyl)hydrazinyl]-5-hydroxyhexanoic acid
Formylmethionyl-leucyl-phenylalanine methyl ester
C22H33N3O5S (451.2140808000001)
ethyl 2-[2-[5-[(3,4-dimethylphenyl)carbamoyl]-6-methyl-2-oxo-3,4-dihydro-1H-pyrimidin-4-yl]phenoxy]propanoate
C25H29N3O5 (451.21071040000004)
2-(butylamino)-N-[4-[5-[[2-(butylamino)-1-oxoethyl]amino]-1,3-benzoxazol-2-yl]phenyl]acetamide
C25H33N5O3 (451.2583268000001)
N-[[2-(diethylamino)ethylamino]-sulfanylidenemethyl]-3-(4-methoxyphenyl)-1-phenyl-4-pyrazolecarboxamide
C24H29N5O2S (451.20418540000003)
N-{3-[(5-cyclopropyl-2-{[3-methyl-1-(2,2,2-trifluoroethyl)-1H-pyrazol-4-yl]amino}pyrimidin-4-yl)amino]propyl}cyclobutanecarboxamide
Ethyl 4-{[1-(mesitylsulfonyl)-4-piperidinyl]carbonyl}-1-piperazinecarboxylate
C22H33N3O5S (451.2140808000001)
7,7-dimethyl-1-(4-methylphenyl)-N-[3-(4-morpholinyl)propyl]-2,5-dioxo-6,8-dihydroquinoline-3-carboxamide
C26H33N3O4 (451.2470938000001)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
2-(trimethylsilyl)ethyl 2-acetamido-2-deoxy-3-O-(beta-D-tyvelopyranosyl)-beta-D-galactopyranoside
(11)-Cytochalasa-6(12),13-diene-1,21-dione-7,9-dihydroxy-16,18-dimethyl-lO-phenyl-(7S*,13E,16S*,18R*,19R*)
C28H37NO4 (451.27224420000005)
1-[(1S)-2-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-(2-piperidin-1-ylethyl)acetamide
C22H33N3O5S (451.2140808000001)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-N-(2-piperidin-1-ylethyl)-1-(pyridin-2-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H33N5O3 (451.2583268000001)
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[3-(trifluoromethyl)phenyl]methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C23H28F3N3O3 (451.2082654000001)
(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-8-(3-methylbut-1-ynyl)-2-[[methyl(5-pyrimidinylmethyl)amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one
C25H33N5O3 (451.2583268000001)
2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C22H33N3O5S (451.2140808000001)
2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C22H33N3O5S (451.2140808000001)
2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C22H33N3O5S (451.2140808000001)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-N-(2-piperidin-1-ylethyl)-1-(pyridin-2-ylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H33N5O3 (451.2583268000001)
(2S,3S,3aR,9bR)-1-(cyclopropanecarbonyl)-3-(hydroxymethyl)-7-(3-methoxyphenyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H29N3O5 (451.21071040000004)
2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C22H33N3O5S (451.2140808000001)
2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C22H33N3O5S (451.2140808000001)
2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C22H33N3O5S (451.2140808000001)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
2-[(1R,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1S,3S,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1S,3R,4aR,9aS)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
(2R,3R,3aS,9bS)-1-[cyclopropyl(oxo)methyl]-3-(hydroxymethyl)-7-(3-methoxyphenyl)-N,N-dimethyl-6-oxo-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C25H29N3O5 (451.21071040000004)
1-[(3aS,4R,9bR)-4-(hydroxymethyl)-8-(2-methoxyphenyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
C26H33N3O4 (451.2470938000001)
1-[(1R)-2-[(3-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]ethanone
(2-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
(4-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-1,9-dimethyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
1-[(1R)-1-[(4-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-1-propanone
2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(4-methylphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-piperidinyl)ethyl]acetamide
C22H33N3O5S (451.2140808000001)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-[(1-oxo-2-pyridin-4-ylethyl)amino]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]cyclobutanecarboxamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(2-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
2-[(1S,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1S,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1R,3R,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
2-[(1R,3S,4aS,9aR)-6-[[anilino(oxo)methyl]amino]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-(cyclopropylmethyl)acetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(3-pyridinylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-2-cyclopropylacetamide
C25H29N3O5 (451.21071040000004)
(4-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-1,9-dimethyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanone
1-[(1S)-1-[(4-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-9-methyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-1-propanone
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-[(dipropylamino)methyl]-N-[(E)-[(E)-2-methyl-3-phenylprop-2-enylidene]amino]triazole-4-carboxamide
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-hexadec-9-enoate
C21H42NO7P (451.26987520000006)
[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate
C21H42NO7P (451.26987520000006)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] propanoate
C21H42NO7P (451.26987520000006)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tetradec-9-enoxy]propan-2-yl] acetate
C21H42NO7P (451.26987520000006)
[1-acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] (Z)-tridec-9-enoate
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-hexadec-9-enoate
C21H42NO7P (451.26987520000006)
[(2R)-3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (E)-hexadec-7-enoate
C21H42NO7P (451.26987520000006)
1-(9Z-hexadecenoyl)-glycero-3-phosphoethanolamine
C21H42NO7P (451.26987520000006)
1-(10E-undecenyl)-2-acetyl-sn-glycero-3-phosphocholine
C21H42NO7P (451.26987520000006)
beta-D-Tyvp-(1->3)-beta-D-GalpNAc-OCH2CH2SiMe3
An amino disaccharide consisting of 2-(trimethylsilyl)ethyl N-acetyl-beta-D-galactosaminide having a beta-D-tyvelosyl residue attached at the 3-position.
PE(16:1)
C21H42NO7P (451.26987520000006)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
PE(15:1)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
AMPK-IN-3
C25H33N5O3 (451.2583268000001)
AMPK-IN-3 (compound 67) is a potent and selective AMPK inhibitor with IC50s of 60.7, 107 and 3820 nM for AMPK (α2), AMPK (α1) and KDR, respectively. AMPK-IN-3 inhibits AMPK does not affect cell viability or cause significant cytotoxicity in K562 cells. AMPK-IN-3 can be used in study of cancer[1].
AZ304
AZ304 is an ATP-competitive dual BRAF kinase inhibitor, potently inhibits wild type BRAF, V600E mutant BRAF and wild type CRAF, with IC50s of 79 nM, 38 nM and 68 nM, respectively. AZ304 also has significant effect on other kinases, such as p38 (IC50, 6 nM), CSF1R (IC50, 35 nM). Anti-tumor activity[1].
9,20-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11,13-heptaen-15-one
C26H29NO6 (451.19947740000003)
(3r,3as,4r,6r,6as,10r,12s,13s,15ar)-3-benzyl-1,6,13-trihydroxy-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,12h,13h,14h-cycloundeca[d]isoindol-15-one
C28H37NO4 (451.27224420000005)
5-{[(10s)-11-chloro-10-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl]oxy}-6-methoxy-3h-isoindole-1,4-diol
C24H34ClNO5 (451.2125384000001)
(1s,2r,5s,7r,11s,14s)-5,11-dihydroxy-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-9,16(24),17,19,21-pentaen-8-one
C27H33NO5 (451.23586080000007)
(1s,2r,5s,7s,8r,9r,11s,16r)-7-(2-hydroxypropan-2-yl)-1,2-dimethyl-6,10,13-trioxa-25-azaoctacyclo[14.10.0.0²,¹².0⁵,¹¹.0⁹,¹¹.0¹²,¹⁴.0¹⁸,²⁶.0¹⁹,²⁴]hexacosa-18(26),19,21,23-tetraen-8-ol
C27H33NO5 (451.23586080000007)
16-benzyl-5,7,14-trimethyl-13-methylidene-17-azatetracyclo[9.7.0.0¹,¹⁵.0³,¹⁰]octadeca-4,17-diene-2,9,12,18-tetrol
C28H37NO4 (451.27224420000005)
(1r,2r,3r,4r,5s,6r,8r,12s,13s,16r,19s,20r,21r)-14-ethyl-4,6,19-trimethoxy-9,11-dioxa-14-azaheptacyclo[10.7.2.1²,⁵.0¹,¹³.0³,⁸.0⁸,¹².0¹⁶,²⁰]docosane-2,21-diol
methyl (2s,3s,5s,6r,10s)-5-hydroxy-2,6-dimethyl-21-oxo-3-(2-oxopropyl)-14-oxa-8-azahexacyclo[11.6.1.1⁵,¹⁹.0²,¹⁰.0³,⁸.0¹⁷,²⁰]henicosa-1(19),13(20),15,17-tetraene-18-carboxylate
C26H29NO6 (451.19947740000003)
(3s,3ar,4s,6ar,15r)-3-benzyl-4,10,12-trimethyl-5-methylidene-3h,3ah,4h,6h,6ah,9h,10h,11h,15h-cycloundeca[d]isoindole-1,6,12,15-tetrol
C28H37NO4 (451.27224420000005)
(1r,2r,3s,7r,9r,10s,11r,12s,14s,15r,16s)-16-benzyl-5,7,14-trimethyl-13-methylidene-17-azatetracyclo[9.7.0.0¹,¹⁵.0³,¹⁰]octadeca-4,17-diene-2,9,12,18-tetrol
C28H37NO4 (451.27224420000005)